Deep Curettage – [DEDS-0051] at Dr. Essa Lab

Understanding Deep Curettage – [DEDS-0051] at Dr. Essa Lab

Deep Curettage – [DEDS-0051] at Dr. Essa Lab is a specialized histopathological examination performed on tissue specimens obtained through deep curettage procedures. Curettage is a surgical or diagnostic technique that involves scraping the internal lining of an organ, cavity, or deep tissue lesion using a specialized, loop-shaped instrument known as a curette. While most commonly associated with gynecological evaluations—specifically endometrial curettage to assess the uterine lining—deep curettage can also be performed on dermatological lesions, bone cavities, or deep oral mucosal sites. The tissue collected during this procedure is of paramount diagnostic value, as it provides a direct window into cellular architecture, tissue organization, and potential pathological processes.

At Dr. Essa Lab, a premier diagnostic institution in Karachi, Pakistan, the Deep Curettage – [DEDS-0051] test represents a gold-standard histopathological analysis. Once the clinical specialist performs the curettage and retrieves the tissue, the specimen is immediately preserved and sent to our state-of-the-art laboratory. Here, our team of highly experienced consultant pathologists, histotechnologists, and laboratory professionals process the tissue using advanced tissue-embedding, microtomy, and staining techniques. The primary objective of this microscopic evaluation is to identify cellular abnormalities, inflammatory conditions, pre-cancerous lesions, or overt malignancies, thereby enabling clinicians to formulate precise, evidence-based treatment plans for their patients.

The clinical importance of Deep Curettage – [DEDS-0051] cannot be overstated. In gynecology, it is the definitive method for evaluating abnormal uterine bleeding, investigating postmenopausal bleeding, and ruling out endometrial hyperplasia or endometrial carcinoma. In other medical specialties, such as dermatology or orthopedics, deep curettage histopathology helps differentiate benign inflammatory lesions from aggressive neoplastic growths. By choosing Dr. Essa Lab, patients and referring physicians across Karachi benefit from decades of diagnostic expertise, rigorous quality control, and a commitment to clinical accuracy that has made our institution a trusted household name in healthcare since 1987.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure both patient safety during the clinical procedure and the integrity of the tissue specimen submitted to Dr. Essa Lab. Depending on the anatomical site of the curettage, preparation guidelines may vary:

• Gynecological Curettage (Endometrial/Endocervical): If the procedure is to be performed under local or general anesthesia, patients must observe a strict fasting period (typically 6 to 8 hours prior to the procedure). It is crucial to schedule the procedure in consultation with your gynecologist, often timed with specific phases of the menstrual cycle depending on the clinical indication.
• Medication Review: Patients must inform their physician of all ongoing medications, particularly blood thinners, anticoagulants, or antiplatelet agents (such as aspirin, warfarin, or clopidogrel), as these may need to be temporarily discontinued to minimize bleeding risks.
• Dermatological or Deep Tissue Curettage: For localized skin or mucosal curettage, fasting is generally not required unless conscious sedation is planned. The area should be kept clean and free of topical creams, cosmetics, or self-treatment agents.
• Specimen Preservation and Transport: For the laboratory phase, the tissue obtained must be immediately placed in a container filled with 10% neutral buffered formalin. The volume of formalin should be at least ten times the volume of the tissue specimen to ensure adequate fixation and prevent autolysis (tissue self-digestion). The container must be clearly labeled with the patient\’s full name, age, gender, specimen source, and the specific test code: Deep Curettage – [DEDS-0051].

During the Procedure

The overall diagnostic process for Deep Curettage – [DEDS-0051] is divided into two distinct phases: the clinical collection phase (performed at the hospital or clinic) and the laboratory analysis phase (performed at Dr. Essa Lab).

The clinical collection phase is performed by a qualified specialist (such as a gynecologist, dermatologist, or surgeon). For an endometrial curettage, the patient is positioned in the lithotomy position. The clinician dilates the cervix if necessary and carefully inserts the curette into the uterine cavity to scrape the lining. This process may cause mild cramping or pressure. For skin or deep tissue lesions, local anesthesia is administered to numb the area before the curette is used to scrape the deep layers of the lesion. The collected tissue is immediately transferred into the formalin fixative.

Once the specimen arrives at Dr. Essa Lab, the laboratory analysis phase begins. Our histotechnologists perform a detailed gross examination, documenting the specimen\’s size, color, consistency, and weight. The tissue then undergoes automated processing, which includes dehydration in graded alcohols, clearing in xylene, and impregnation with paraffin wax. The tissue is then embedded into paraffin blocks, and ultra-thin sections (4-5 microns) are cut using a high-precision microtome. These sections are mounted on glass slides and stained with Hematoxylin and Eosin (H&E) dyes. Finally, a Consultant Pathologist examines the slides under a high-power microscope to evaluate the cellular structures, glandular patterns, and stromal features, generating a comprehensive diagnostic report.

When is a Deep Curettage – [DEDS-0051] Performed?

Investigation of Abnormal Uterine Bleeding (AUB)

Abnormal uterine bleeding, including menorrhagia (excessively heavy periods), metrorrhagia (bleeding between periods), or irregular menstrual cycles, is one of the primary indications for endometrial deep curettage. Clinicians request the Deep Curettage – [DEDS-0051] test to determine the underlying cause of this bleeding. The histopathological analysis can distinguish between hormonal imbalances, benign structural abnormalities (such as endometrial polyps or submucosal fibroids), chronic inflammatory states, and neoplastic changes, allowing for targeted therapeutic intervention.

Diagnostic Evaluation of Postmenopausal Bleeding

Any vaginal bleeding occurring after menopause is considered a red flag and requires immediate, thorough investigation to rule out malignancy. Postmenopausal bleeding can be caused by benign conditions like endometrial atrophy or senile endometritis, but it is also a primary symptom of endometrial hyperplasia and endometrial cancer. Physicians rely on the Deep Curettage – [DEDS-0051] histopathology report to obtain a definitive diagnosis, as microscopic evaluation of the curetted tissue is the only definitive way to confirm or exclude uterine malignancies in postmenopausal patients.

Identification of Endometrial Hyperplasia and Malignancy

Endometrial hyperplasia is an abnormal proliferation of the uterine lining, often driven by estrogen exposure unopposed by progesterone. This condition is clinically significant because certain forms, particularly atypical hyperplasia, are direct precursors to endometrioid adenocarcinoma (endometrial cancer). A deep curettage provides a comprehensive sample of the endometrial cavity, which is then analyzed at Dr. Essa Lab to classify the hyperplasia (simple vs. complex, with or without cytological atypia) or to identify invasive malignant cells, guiding surgical and oncological decision-making.

Assessment of Retained Products of Conception (RPOC)

Following a miscarriage, abortion, or childbirth, some placental or fetal tissue may remain inside the uterine cavity, a condition known as retained products of conception (RPOC). This can lead to persistent uterine bleeding, pelvic pain, and severe pelvic infections (endometritis). When a clinician performs a therapeutic curettage to clear the uterus, the retrieved tissue is submitted for Deep Curettage – [DEDS-0051] analysis to histologically confirm the presence of chorionic villi or decidual tissue, ensuring the uterine cavity has been successfully cleared and ruling out gestational trophoblastic diseases.

Diagnosis of Chronic Endometritis and Specific Infections

Chronic pelvic pain, unexplained infertility, and recurrent pregnancy losses can sometimes be traced back to chronic endometritis, a persistent, low-grade inflammation of the endometrial lining. Because this condition is often asymptomatic or presents with non-specific symptoms, it is frequently diagnosed histopathologically. The Deep Curettage – [DEDS-0051] test allows pathologists to identify the characteristic presence of plasma cells within the endometrial stroma, as well as specific infectious etiologies such as tuberculous endometritis, which remains a significant cause of infertility in developing regions.

What Does a Deep Curettage – [DEDS-0051] Detect?

The histopathological evaluation of deep curettage specimens at Dr. Essa Lab is highly sensitive and capable of detecting a wide array of physiological, inflammatory, pre-neoplastic, and neoplastic conditions. Key findings that can be identified through this analysis include:

• Proliferative Endometrium: Normal physiological state corresponding to the estrogen-dominant follicular phase of the menstrual cycle.
• Secretory Endometrium: Normal physiological state corresponding to the progesterone-dominant luteal phase, indicating that ovulation has occurred.
• Disordered Proliferative Endometrium: An irregular proliferative pattern often associated with anovulatory cycles and estrogen excess.
• Endometrial Atrophy: Thinning of the endometrial lining, common in postmenopausal women, which can paradoxically cause localized bleeding.
• Simple Endometrial Hyperplasia without Atypia: Benign glandular crowding and dilation without abnormal cellular features, carrying a very low risk of progression to cancer.
• Complex Endometrial Hyperplasia without Atypia: Significant glandular crowding and structural complexity without cytological atypia.
• Atypical Endometrial Hyperplasia (Endometrial Intraepithelial Neoplasia – EIN): Highly crowded glands showing cytological atypia, representing a premalignant state with a high risk of progression to adenocarcinoma.
• Endometrioid Adenocarcinoma: The most common form of endometrial cancer, characterized by malignant epithelial cells forming abnormal glandular structures.
• Serous Carcinoma of the Endometrium: An aggressive, non-estrogen-dependent type of uterine cancer that typically occurs in older women.
• Clear Cell Carcinoma of the Endometrium: Another high-grade, aggressive variant of endometrial malignancy requiring prompt oncological management.
• Endometrial Polyps: Benign localized overgrowths of endometrial glands and stroma, often presenting with abnormal bleeding.
• Chronic Endometritis: Persistent inflammation marked by the diagnostic presence of plasma cells in the endometrial stroma.
• Acute Endometritis: Active inflammation characterized by dense neutrophilic infiltrates, often occurring post-partum or post-abortion.
• Tuberculous Endometritis: Chronic granulomatous inflammation with caseating necrosis and giant cells, indicative of Mycobacterium tuberculosis infection.
• Retained Products of Conception: Presence of degenerated chorionic villi, syncytiotrophoblasts, and decidual tissue confirming incomplete miscarriage or delivery.
• Arias-Stella Reaction: A benign, pregnancy-associated hypersecretory change in endometrial glands that can mimic malignancy under the microscope.
• Squamous Metaplasia: A benign cellular adaptation where the normal glandular epithelium is replaced by squamous-like cells.
• Submucosal Leiomyoma (Fibroids): Fragments of smooth muscle tissue originating from benign uterine tumors that have protruded into the endometrial cavity.
• Decidualized Endometrium: Specialized stromal changes induced by high progesterone levels, typical of pregnancy or exogenous hormone therapy.
• Foreign Body Granuloma: Inflammatory reaction to foreign materials, such as retained intrauterine device (IUD) components or suture material.
• Endocervical Tissue: Presence of mucinous endocervical glands, helping the pathologist determine the anatomical boundaries of the curettage.
• Atypical Squamous Cells: Abnormal squamous cells that may suggest cervical involvement or extension of a cervical lesion.
• Pyometra-Associated Changes: Inflammatory and necrotic debris resulting from an accumulation of pus within the uterine cavity.
• Malignant Mixed Müllerian Tumor (MMMT / Carcinosarcoma): A rare, highly aggressive biphasic tumor containing both malignant epithelial and mesenchymal components.

Turnaround Time and Report Access at Dr. Essa Lab

Histopathological analysis is a highly meticulous process that involves multiple chemical, physical, and analytical steps. Unlike routine blood tests, tissue specimens require overnight processing, embedding, sectioning, and specialized staining before they can be reviewed by a pathologist. At Dr. Essa Lab, we understand the anxiety associated with waiting for biopsy results, and we strive to balance absolute diagnostic accuracy with clinical efficiency.

The typical turnaround time for the Deep Curettage – [DEDS-0051] test is approximately 5 to 7 working days. This timeframe ensures that our histotechnologists can perform optimal tissue processing and that our Consultant Pathologists have sufficient time to perform a thorough microscopic evaluation, order special stains or immunohistochemistry (IHC) if required, and formulate a precise diagnosis. Once the report is finalized and signed off by the consultant, patients receive an automated SMS notification. Reports can be accessed and downloaded instantly via the Dr. Essa Lab official website portal or mobile application, or they can be collected in person from any of our convenient diagnostic centers across Karachi and Pakistan.

Deep Curettage – [DEDS-0051] Findings Overview

The following table outlines the key anatomical and histological parameters evaluated during the microscopic analysis of a deep curettage specimen, contrasting normal physiological findings with potential pathological abnormalities:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Endometrial Glands	Regular size, shape, and distribution corresponding to the menstrual phase (proliferative or secretory).	Glandular crowding, structural complexity, cystic dilation, or atypical branching.
Endometrial Stroma	Normal cellularity, spindle-shaped stromal cells without atypia or excessive mitotic activity.	Hypercellularity, stromal breakdown, sarcomatous changes, or dense inflammatory infiltrates.
Gland-to-Stroma Ratio	Balanced ratio typical of the physiological cycle (glands are well-spaced by stroma).	Markedly increased ratio (gland crowding with minimal intervening stroma), indicating hyperplasia.
Nuclear Morphology	Uniform, oval nuclei with finely dispersed chromatin and no atypical mitotic figures.	Nuclear pleomorphism, hyperchromasia, prominent nucleoli, and atypical or frequent mitoses.
Inflammatory Infiltrate	Minimal or absent inflammatory cells (except during normal menstrual shedding).	Abundant plasma cells (chronic endometritis), sheets of neutrophils (acute endometritis), or granulomas.
Gestational Elements	Absent in non-pregnant states.	Presence of chorionic villi, trophoblastic proliferation, or decidual tissue (indicating RPOC).
Vascular Architecture	Normal spiral arterioles and capillaries without thrombosis, atypia, or endothelial proliferation.	Thick-walled, irregular vessels, plexiform capillary networks, or neoplastic vascular invasion.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Deep Curettage – [DEDS-0051]?

• Decades of Diagnostic Trust: Established in 1987, Dr. Essa Lab is one of Pakistan\’s pioneer diagnostic networks, trusted by generations of patients and physicians.
• Expert Consultant Pathologists: Your tissue specimens are evaluated by highly qualified, board-certified histopathologists with extensive experience in gynecological and general surgical pathology.
• State-of-the-Art Histopathology Lab: Our laboratory is equipped with advanced automated tissue processors, high-precision microtomes, and premium staining systems to ensure superior slide quality.
• Rigorous Quality Assurance: We adhere to strict internal and external quality control protocols, minimizing the risk of diagnostic errors and ensuring highly reproducible results.
• Comprehensive Diagnostic Capabilities: If a specimen requires advanced testing, Dr. Essa Lab offers a full suite of immunohistochemistry (IHC) markers to differentiate complex lesions.
• Convenient Report Access: Patients can easily download their diagnostic reports online through our secure web portal, mobile app, or receive them via WhatsApp and SMS alerts.
• Extensive Network in Karachi: With numerous collection centers across Karachi and other major cities, submitting specimens and collecting reports is highly convenient.
• Patient-Centric Care: We prioritize patient comfort, safety, and confidentiality, providing compassionate care and professional guidance throughout your diagnostic journey.